Medical Care
Global Clinical Trial Equipment & Ancillary Solutions Market Research Report 2025
- Mar 11, 25
- ID: 13586
- Pages: 84
- Figures: 83
- Views: 20
The global market for Clinical Trial Equipment & Ancillary Solutions was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Clinical Trial Equipment & Ancillary Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Clinical Trial Equipment & Ancillary Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Clinical Trial Equipment & Ancillary Solutions in Contract Research Organizations (CROs) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Clinical Trial Equipment & Ancillary Solutions include Almac, Ancillare, Avantor, Emsere, Eurofins Scientific, Imperial Clinical Research Services, IRM Europe, Marken, Myonex, Parexel International, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Equipment & Ancillary Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Equipment & Ancillary Solutions.
The Clinical Trial Equipment & Ancillary Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Trial Equipment & Ancillary Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial Equipment & Ancillary Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Almac
Ancillare
Avantor
Emsere
Eurofins Scientific
Imperial Clinical Research Services
IRM Europe
Marken
Myonex
Parexel International
Piramal Pharma
Recipharm
Thermo Fisher Scientific
Woodley Equipment
Quipment SAS
Segment by Type
Biologic Drugs
Small Molecules
Medical Devices
Segment by Application
Contract Research Organizations (CROs)
Medical Devices Companies
Pharmaceutical & Biotechnology Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Equipment & Ancillary Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Clinical Trial Equipment & Ancillary Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Clinical Trial Equipment & Ancillary Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Clinical Trial Equipment & Ancillary Solutions in Contract Research Organizations (CROs) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Clinical Trial Equipment & Ancillary Solutions include Almac, Ancillare, Avantor, Emsere, Eurofins Scientific, Imperial Clinical Research Services, IRM Europe, Marken, Myonex, Parexel International, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Equipment & Ancillary Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Equipment & Ancillary Solutions.
The Clinical Trial Equipment & Ancillary Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Trial Equipment & Ancillary Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial Equipment & Ancillary Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Almac
Ancillare
Avantor
Emsere
Eurofins Scientific
Imperial Clinical Research Services
IRM Europe
Marken
Myonex
Parexel International
Piramal Pharma
Recipharm
Thermo Fisher Scientific
Woodley Equipment
Quipment SAS
Segment by Type
Biologic Drugs
Small Molecules
Medical Devices
Segment by Application
Contract Research Organizations (CROs)
Medical Devices Companies
Pharmaceutical & Biotechnology Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Equipment & Ancillary Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biologic Drugs
1.2.3 Small Molecules
1.2.4 Medical Devices
1.3 Market by Application
1.3.1 Global Clinical Trial Equipment & Ancillary Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Contract Research Organizations (CROs)
1.3.3 Medical Devices Companies
1.3.4 Pharmaceutical & Biotechnology Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Equipment & Ancillary Solutions Market Perspective (2020-2031)
2.2 Global Clinical Trial Equipment & Ancillary Solutions Growth Trends by Region
2.2.1 Global Clinical Trial Equipment & Ancillary Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Region (2020-2025)
2.2.3 Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Region (2026-2031)
2.3 Clinical Trial Equipment & Ancillary Solutions Market Dynamics
2.3.1 Clinical Trial Equipment & Ancillary Solutions Industry Trends
2.3.2 Clinical Trial Equipment & Ancillary Solutions Market Drivers
2.3.3 Clinical Trial Equipment & Ancillary Solutions Market Challenges
2.3.4 Clinical Trial Equipment & Ancillary Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Equipment & Ancillary Solutions Players by Revenue
3.1.1 Global Top Clinical Trial Equipment & Ancillary Solutions Players by Revenue (2020-2025)
3.1.2 Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Players (2020-2025)
3.2 Global Clinical Trial Equipment & Ancillary Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Trial Equipment & Ancillary Solutions Revenue
3.4 Global Clinical Trial Equipment & Ancillary Solutions Market Concentration Ratio
3.4.1 Global Clinical Trial Equipment & Ancillary Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Equipment & Ancillary Solutions Revenue in 2024
3.5 Global Key Players of Clinical Trial Equipment & Ancillary Solutions Head office and Area Served
3.6 Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Product and Application
3.7 Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Equipment & Ancillary Solutions Breakdown Data by Type
4.1 Global Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Type (2020-2025)
4.2 Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Type (2026-2031)
5 Clinical Trial Equipment & Ancillary Solutions Breakdown Data by Application
5.1 Global Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Application (2020-2025)
5.2 Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Trial Equipment & Ancillary Solutions Market Size (2020-2031)
6.2 North America Clinical Trial Equipment & Ancillary Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025)
6.4 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial Equipment & Ancillary Solutions Market Size (2020-2031)
7.2 Europe Clinical Trial Equipment & Ancillary Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025)
7.4 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size (2020-2031)
8.2 Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trial Equipment & Ancillary Solutions Market Size (2020-2031)
9.2 Latin America Clinical Trial Equipment & Ancillary Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025)
9.4 Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size (2020-2031)
10.2 Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Almac
11.1.1 Almac Company Details
11.1.2 Almac Business Overview
11.1.3 Almac Clinical Trial Equipment & Ancillary Solutions Introduction
11.1.4 Almac Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.1.5 Almac Recent Development
11.2 Ancillare
11.2.1 Ancillare Company Details
11.2.2 Ancillare Business Overview
11.2.3 Ancillare Clinical Trial Equipment & Ancillary Solutions Introduction
11.2.4 Ancillare Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.2.5 Ancillare Recent Development
11.3 Avantor
11.3.1 Avantor Company Details
11.3.2 Avantor Business Overview
11.3.3 Avantor Clinical Trial Equipment & Ancillary Solutions Introduction
11.3.4 Avantor Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.3.5 Avantor Recent Development
11.4 Emsere
11.4.1 Emsere Company Details
11.4.2 Emsere Business Overview
11.4.3 Emsere Clinical Trial Equipment & Ancillary Solutions Introduction
11.4.4 Emsere Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.4.5 Emsere Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Clinical Trial Equipment & Ancillary Solutions Introduction
11.5.4 Eurofins Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.5.5 Eurofins Scientific Recent Development
11.6 Imperial Clinical Research Services
11.6.1 Imperial Clinical Research Services Company Details
11.6.2 Imperial Clinical Research Services Business Overview
11.6.3 Imperial Clinical Research Services Clinical Trial Equipment & Ancillary Solutions Introduction
11.6.4 Imperial Clinical Research Services Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.6.5 Imperial Clinical Research Services Recent Development
11.7 IRM Europe
11.7.1 IRM Europe Company Details
11.7.2 IRM Europe Business Overview
11.7.3 IRM Europe Clinical Trial Equipment & Ancillary Solutions Introduction
11.7.4 IRM Europe Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.7.5 IRM Europe Recent Development
11.8 Marken
11.8.1 Marken Company Details
11.8.2 Marken Business Overview
11.8.3 Marken Clinical Trial Equipment & Ancillary Solutions Introduction
11.8.4 Marken Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.8.5 Marken Recent Development
11.9 Myonex
11.9.1 Myonex Company Details
11.9.2 Myonex Business Overview
11.9.3 Myonex Clinical Trial Equipment & Ancillary Solutions Introduction
11.9.4 Myonex Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.9.5 Myonex Recent Development
11.10 Parexel International
11.10.1 Parexel International Company Details
11.10.2 Parexel International Business Overview
11.10.3 Parexel International Clinical Trial Equipment & Ancillary Solutions Introduction
11.10.4 Parexel International Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.10.5 Parexel International Recent Development
11.11 Piramal Pharma
11.11.1 Piramal Pharma Company Details
11.11.2 Piramal Pharma Business Overview
11.11.3 Piramal Pharma Clinical Trial Equipment & Ancillary Solutions Introduction
11.11.4 Piramal Pharma Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.11.5 Piramal Pharma Recent Development
11.12 Recipharm
11.12.1 Recipharm Company Details
11.12.2 Recipharm Business Overview
11.12.3 Recipharm Clinical Trial Equipment & Ancillary Solutions Introduction
11.12.4 Recipharm Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.12.5 Recipharm Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Clinical Trial Equipment & Ancillary Solutions Introduction
11.13.4 Thermo Fisher Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 Woodley Equipment
11.14.1 Woodley Equipment Company Details
11.14.2 Woodley Equipment Business Overview
11.14.3 Woodley Equipment Clinical Trial Equipment & Ancillary Solutions Introduction
11.14.4 Woodley Equipment Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.14.5 Woodley Equipment Recent Development
11.15 Quipment SAS
11.15.1 Quipment SAS Company Details
11.15.2 Quipment SAS Business Overview
11.15.3 Quipment SAS Clinical Trial Equipment & Ancillary Solutions Introduction
11.15.4 Quipment SAS Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.15.5 Quipment SAS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biologic Drugs
1.2.3 Small Molecules
1.2.4 Medical Devices
1.3 Market by Application
1.3.1 Global Clinical Trial Equipment & Ancillary Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Contract Research Organizations (CROs)
1.3.3 Medical Devices Companies
1.3.4 Pharmaceutical & Biotechnology Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Equipment & Ancillary Solutions Market Perspective (2020-2031)
2.2 Global Clinical Trial Equipment & Ancillary Solutions Growth Trends by Region
2.2.1 Global Clinical Trial Equipment & Ancillary Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Region (2020-2025)
2.2.3 Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Region (2026-2031)
2.3 Clinical Trial Equipment & Ancillary Solutions Market Dynamics
2.3.1 Clinical Trial Equipment & Ancillary Solutions Industry Trends
2.3.2 Clinical Trial Equipment & Ancillary Solutions Market Drivers
2.3.3 Clinical Trial Equipment & Ancillary Solutions Market Challenges
2.3.4 Clinical Trial Equipment & Ancillary Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Equipment & Ancillary Solutions Players by Revenue
3.1.1 Global Top Clinical Trial Equipment & Ancillary Solutions Players by Revenue (2020-2025)
3.1.2 Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Players (2020-2025)
3.2 Global Clinical Trial Equipment & Ancillary Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Trial Equipment & Ancillary Solutions Revenue
3.4 Global Clinical Trial Equipment & Ancillary Solutions Market Concentration Ratio
3.4.1 Global Clinical Trial Equipment & Ancillary Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Equipment & Ancillary Solutions Revenue in 2024
3.5 Global Key Players of Clinical Trial Equipment & Ancillary Solutions Head office and Area Served
3.6 Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Product and Application
3.7 Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Equipment & Ancillary Solutions Breakdown Data by Type
4.1 Global Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Type (2020-2025)
4.2 Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Type (2026-2031)
5 Clinical Trial Equipment & Ancillary Solutions Breakdown Data by Application
5.1 Global Clinical Trial Equipment & Ancillary Solutions Historic Market Size by Application (2020-2025)
5.2 Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Trial Equipment & Ancillary Solutions Market Size (2020-2031)
6.2 North America Clinical Trial Equipment & Ancillary Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025)
6.4 North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial Equipment & Ancillary Solutions Market Size (2020-2031)
7.2 Europe Clinical Trial Equipment & Ancillary Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025)
7.4 Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size (2020-2031)
8.2 Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trial Equipment & Ancillary Solutions Market Size (2020-2031)
9.2 Latin America Clinical Trial Equipment & Ancillary Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025)
9.4 Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size (2020-2031)
10.2 Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Almac
11.1.1 Almac Company Details
11.1.2 Almac Business Overview
11.1.3 Almac Clinical Trial Equipment & Ancillary Solutions Introduction
11.1.4 Almac Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.1.5 Almac Recent Development
11.2 Ancillare
11.2.1 Ancillare Company Details
11.2.2 Ancillare Business Overview
11.2.3 Ancillare Clinical Trial Equipment & Ancillary Solutions Introduction
11.2.4 Ancillare Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.2.5 Ancillare Recent Development
11.3 Avantor
11.3.1 Avantor Company Details
11.3.2 Avantor Business Overview
11.3.3 Avantor Clinical Trial Equipment & Ancillary Solutions Introduction
11.3.4 Avantor Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.3.5 Avantor Recent Development
11.4 Emsere
11.4.1 Emsere Company Details
11.4.2 Emsere Business Overview
11.4.3 Emsere Clinical Trial Equipment & Ancillary Solutions Introduction
11.4.4 Emsere Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.4.5 Emsere Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Clinical Trial Equipment & Ancillary Solutions Introduction
11.5.4 Eurofins Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.5.5 Eurofins Scientific Recent Development
11.6 Imperial Clinical Research Services
11.6.1 Imperial Clinical Research Services Company Details
11.6.2 Imperial Clinical Research Services Business Overview
11.6.3 Imperial Clinical Research Services Clinical Trial Equipment & Ancillary Solutions Introduction
11.6.4 Imperial Clinical Research Services Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.6.5 Imperial Clinical Research Services Recent Development
11.7 IRM Europe
11.7.1 IRM Europe Company Details
11.7.2 IRM Europe Business Overview
11.7.3 IRM Europe Clinical Trial Equipment & Ancillary Solutions Introduction
11.7.4 IRM Europe Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.7.5 IRM Europe Recent Development
11.8 Marken
11.8.1 Marken Company Details
11.8.2 Marken Business Overview
11.8.3 Marken Clinical Trial Equipment & Ancillary Solutions Introduction
11.8.4 Marken Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.8.5 Marken Recent Development
11.9 Myonex
11.9.1 Myonex Company Details
11.9.2 Myonex Business Overview
11.9.3 Myonex Clinical Trial Equipment & Ancillary Solutions Introduction
11.9.4 Myonex Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.9.5 Myonex Recent Development
11.10 Parexel International
11.10.1 Parexel International Company Details
11.10.2 Parexel International Business Overview
11.10.3 Parexel International Clinical Trial Equipment & Ancillary Solutions Introduction
11.10.4 Parexel International Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.10.5 Parexel International Recent Development
11.11 Piramal Pharma
11.11.1 Piramal Pharma Company Details
11.11.2 Piramal Pharma Business Overview
11.11.3 Piramal Pharma Clinical Trial Equipment & Ancillary Solutions Introduction
11.11.4 Piramal Pharma Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.11.5 Piramal Pharma Recent Development
11.12 Recipharm
11.12.1 Recipharm Company Details
11.12.2 Recipharm Business Overview
11.12.3 Recipharm Clinical Trial Equipment & Ancillary Solutions Introduction
11.12.4 Recipharm Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.12.5 Recipharm Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Clinical Trial Equipment & Ancillary Solutions Introduction
11.13.4 Thermo Fisher Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 Woodley Equipment
11.14.1 Woodley Equipment Company Details
11.14.2 Woodley Equipment Business Overview
11.14.3 Woodley Equipment Clinical Trial Equipment & Ancillary Solutions Introduction
11.14.4 Woodley Equipment Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.14.5 Woodley Equipment Recent Development
11.15 Quipment SAS
11.15.1 Quipment SAS Company Details
11.15.2 Quipment SAS Business Overview
11.15.3 Quipment SAS Clinical Trial Equipment & Ancillary Solutions Introduction
11.15.4 Quipment SAS Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
11.15.5 Quipment SAS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Biologic Drugs
Table 3. Key Players of Small Molecules
Table 4. Key Players of Medical Devices
Table 5. Global Clinical Trial Equipment & Ancillary Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Clinical Trial Equipment & Ancillary Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Region (2020-2025)
Table 9. Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Region (2026-2031)
Table 11. Clinical Trial Equipment & Ancillary Solutions Market Trends
Table 12. Clinical Trial Equipment & Ancillary Solutions Market Drivers
Table 13. Clinical Trial Equipment & Ancillary Solutions Market Challenges
Table 14. Clinical Trial Equipment & Ancillary Solutions Market Restraints
Table 15. Global Clinical Trial Equipment & Ancillary Solutions Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Players (2020-2025)
Table 17. Global Top Clinical Trial Equipment & Ancillary Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Equipment & Ancillary Solutions as of 2024)
Table 18. Ranking of Global Top Clinical Trial Equipment & Ancillary Solutions Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Clinical Trial Equipment & Ancillary Solutions Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Headquarters and Area Served
Table 21. Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Product and Application
Table 22. Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Type (2020-2025)
Table 26. Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Type (2026-2031)
Table 28. Global Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Application (2020-2025)
Table 30. Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Application (2026-2031)
Table 32. North America Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 47. Almac Company Details
Table 48. Almac Business Overview
Table 49. Almac Clinical Trial Equipment & Ancillary Solutions Product
Table 50. Almac Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 51. Almac Recent Development
Table 52. Ancillare Company Details
Table 53. Ancillare Business Overview
Table 54. Ancillare Clinical Trial Equipment & Ancillary Solutions Product
Table 55. Ancillare Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 56. Ancillare Recent Development
Table 57. Avantor Company Details
Table 58. Avantor Business Overview
Table 59. Avantor Clinical Trial Equipment & Ancillary Solutions Product
Table 60. Avantor Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 61. Avantor Recent Development
Table 62. Emsere Company Details
Table 63. Emsere Business Overview
Table 64. Emsere Clinical Trial Equipment & Ancillary Solutions Product
Table 65. Emsere Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 66. Emsere Recent Development
Table 67. Eurofins Scientific Company Details
Table 68. Eurofins Scientific Business Overview
Table 69. Eurofins Scientific Clinical Trial Equipment & Ancillary Solutions Product
Table 70. Eurofins Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 71. Eurofins Scientific Recent Development
Table 72. Imperial Clinical Research Services Company Details
Table 73. Imperial Clinical Research Services Business Overview
Table 74. Imperial Clinical Research Services Clinical Trial Equipment & Ancillary Solutions Product
Table 75. Imperial Clinical Research Services Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 76. Imperial Clinical Research Services Recent Development
Table 77. IRM Europe Company Details
Table 78. IRM Europe Business Overview
Table 79. IRM Europe Clinical Trial Equipment & Ancillary Solutions Product
Table 80. IRM Europe Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 81. IRM Europe Recent Development
Table 82. Marken Company Details
Table 83. Marken Business Overview
Table 84. Marken Clinical Trial Equipment & Ancillary Solutions Product
Table 85. Marken Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 86. Marken Recent Development
Table 87. Myonex Company Details
Table 88. Myonex Business Overview
Table 89. Myonex Clinical Trial Equipment & Ancillary Solutions Product
Table 90. Myonex Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 91. Myonex Recent Development
Table 92. Parexel International Company Details
Table 93. Parexel International Business Overview
Table 94. Parexel International Clinical Trial Equipment & Ancillary Solutions Product
Table 95. Parexel International Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 96. Parexel International Recent Development
Table 97. Piramal Pharma Company Details
Table 98. Piramal Pharma Business Overview
Table 99. Piramal Pharma Clinical Trial Equipment & Ancillary Solutions Product
Table 100. Piramal Pharma Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 101. Piramal Pharma Recent Development
Table 102. Recipharm Company Details
Table 103. Recipharm Business Overview
Table 104. Recipharm Clinical Trial Equipment & Ancillary Solutions Product
Table 105. Recipharm Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 106. Recipharm Recent Development
Table 107. Thermo Fisher Scientific Company Details
Table 108. Thermo Fisher Scientific Business Overview
Table 109. Thermo Fisher Scientific Clinical Trial Equipment & Ancillary Solutions Product
Table 110. Thermo Fisher Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 111. Thermo Fisher Scientific Recent Development
Table 112. Woodley Equipment Company Details
Table 113. Woodley Equipment Business Overview
Table 114. Woodley Equipment Clinical Trial Equipment & Ancillary Solutions Product
Table 115. Woodley Equipment Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 116. Woodley Equipment Recent Development
Table 117. Quipment SAS Company Details
Table 118. Quipment SAS Business Overview
Table 119. Quipment SAS Clinical Trial Equipment & Ancillary Solutions Product
Table 120. Quipment SAS Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 121. Quipment SAS Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Clinical Trial Equipment & Ancillary Solutions Picture
Figure 2. Global Clinical Trial Equipment & Ancillary Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Type: 2024 VS 2031
Figure 4. Biologic Drugs Features
Figure 5. Small Molecules Features
Figure 6. Medical Devices Features
Figure 7. Global Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Application: 2024 VS 2031
Figure 9. Contract Research Organizations (CROs) Case Studies
Figure 10. Medical Devices Companies Case Studies
Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
Figure 12. Clinical Trial Equipment & Ancillary Solutions Report Years Considered
Figure 13. Global Clinical Trial Equipment & Ancillary Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Clinical Trial Equipment & Ancillary Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Region: 2024 VS 2031
Figure 16. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Players in 2024
Figure 17. Global Top Clinical Trial Equipment & Ancillary Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Equipment & Ancillary Solutions as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Clinical Trial Equipment & Ancillary Solutions Revenue in 2024
Figure 19. North America Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Clinical Trial Equipment & Ancillary Solutions Market Share by Country (2020-2031)
Figure 21. United States Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Clinical Trial Equipment & Ancillary Solutions Market Share by Country (2020-2031)
Figure 25. Germany Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Share by Region (2020-2031)
Figure 33. China Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Clinical Trial Equipment & Ancillary Solutions Market Share by Country (2020-2031)
Figure 41. Mexico Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Share by Country (2020-2031)
Figure 45. Turkey Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Almac Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 49. Ancillare Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 50. Avantor Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 51. Emsere Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 52. Eurofins Scientific Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 53. Imperial Clinical Research Services Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 54. IRM Europe Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 55. Marken Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 56. Myonex Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 57. Parexel International Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 58. Piramal Pharma Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 59. Recipharm Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 61. Woodley Equipment Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 62. Quipment SAS Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Biologic Drugs
Table 3. Key Players of Small Molecules
Table 4. Key Players of Medical Devices
Table 5. Global Clinical Trial Equipment & Ancillary Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Clinical Trial Equipment & Ancillary Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Region (2020-2025)
Table 9. Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Region (2026-2031)
Table 11. Clinical Trial Equipment & Ancillary Solutions Market Trends
Table 12. Clinical Trial Equipment & Ancillary Solutions Market Drivers
Table 13. Clinical Trial Equipment & Ancillary Solutions Market Challenges
Table 14. Clinical Trial Equipment & Ancillary Solutions Market Restraints
Table 15. Global Clinical Trial Equipment & Ancillary Solutions Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Players (2020-2025)
Table 17. Global Top Clinical Trial Equipment & Ancillary Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Equipment & Ancillary Solutions as of 2024)
Table 18. Ranking of Global Top Clinical Trial Equipment & Ancillary Solutions Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Clinical Trial Equipment & Ancillary Solutions Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Headquarters and Area Served
Table 21. Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Product and Application
Table 22. Global Key Players of Clinical Trial Equipment & Ancillary Solutions, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Clinical Trial Equipment & Ancillary Solutions Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Type (2020-2025)
Table 26. Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Type (2026-2031)
Table 28. Global Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Application (2020-2025)
Table 30. Global Clinical Trial Equipment & Ancillary Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Clinical Trial Equipment & Ancillary Solutions Revenue Market Share by Application (2026-2031)
Table 32. North America Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 47. Almac Company Details
Table 48. Almac Business Overview
Table 49. Almac Clinical Trial Equipment & Ancillary Solutions Product
Table 50. Almac Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 51. Almac Recent Development
Table 52. Ancillare Company Details
Table 53. Ancillare Business Overview
Table 54. Ancillare Clinical Trial Equipment & Ancillary Solutions Product
Table 55. Ancillare Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 56. Ancillare Recent Development
Table 57. Avantor Company Details
Table 58. Avantor Business Overview
Table 59. Avantor Clinical Trial Equipment & Ancillary Solutions Product
Table 60. Avantor Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 61. Avantor Recent Development
Table 62. Emsere Company Details
Table 63. Emsere Business Overview
Table 64. Emsere Clinical Trial Equipment & Ancillary Solutions Product
Table 65. Emsere Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 66. Emsere Recent Development
Table 67. Eurofins Scientific Company Details
Table 68. Eurofins Scientific Business Overview
Table 69. Eurofins Scientific Clinical Trial Equipment & Ancillary Solutions Product
Table 70. Eurofins Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 71. Eurofins Scientific Recent Development
Table 72. Imperial Clinical Research Services Company Details
Table 73. Imperial Clinical Research Services Business Overview
Table 74. Imperial Clinical Research Services Clinical Trial Equipment & Ancillary Solutions Product
Table 75. Imperial Clinical Research Services Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 76. Imperial Clinical Research Services Recent Development
Table 77. IRM Europe Company Details
Table 78. IRM Europe Business Overview
Table 79. IRM Europe Clinical Trial Equipment & Ancillary Solutions Product
Table 80. IRM Europe Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 81. IRM Europe Recent Development
Table 82. Marken Company Details
Table 83. Marken Business Overview
Table 84. Marken Clinical Trial Equipment & Ancillary Solutions Product
Table 85. Marken Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 86. Marken Recent Development
Table 87. Myonex Company Details
Table 88. Myonex Business Overview
Table 89. Myonex Clinical Trial Equipment & Ancillary Solutions Product
Table 90. Myonex Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 91. Myonex Recent Development
Table 92. Parexel International Company Details
Table 93. Parexel International Business Overview
Table 94. Parexel International Clinical Trial Equipment & Ancillary Solutions Product
Table 95. Parexel International Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 96. Parexel International Recent Development
Table 97. Piramal Pharma Company Details
Table 98. Piramal Pharma Business Overview
Table 99. Piramal Pharma Clinical Trial Equipment & Ancillary Solutions Product
Table 100. Piramal Pharma Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 101. Piramal Pharma Recent Development
Table 102. Recipharm Company Details
Table 103. Recipharm Business Overview
Table 104. Recipharm Clinical Trial Equipment & Ancillary Solutions Product
Table 105. Recipharm Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 106. Recipharm Recent Development
Table 107. Thermo Fisher Scientific Company Details
Table 108. Thermo Fisher Scientific Business Overview
Table 109. Thermo Fisher Scientific Clinical Trial Equipment & Ancillary Solutions Product
Table 110. Thermo Fisher Scientific Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 111. Thermo Fisher Scientific Recent Development
Table 112. Woodley Equipment Company Details
Table 113. Woodley Equipment Business Overview
Table 114. Woodley Equipment Clinical Trial Equipment & Ancillary Solutions Product
Table 115. Woodley Equipment Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 116. Woodley Equipment Recent Development
Table 117. Quipment SAS Company Details
Table 118. Quipment SAS Business Overview
Table 119. Quipment SAS Clinical Trial Equipment & Ancillary Solutions Product
Table 120. Quipment SAS Revenue in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025) & (US$ Million)
Table 121. Quipment SAS Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Clinical Trial Equipment & Ancillary Solutions Picture
Figure 2. Global Clinical Trial Equipment & Ancillary Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Type: 2024 VS 2031
Figure 4. Biologic Drugs Features
Figure 5. Small Molecules Features
Figure 6. Medical Devices Features
Figure 7. Global Clinical Trial Equipment & Ancillary Solutions Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Application: 2024 VS 2031
Figure 9. Contract Research Organizations (CROs) Case Studies
Figure 10. Medical Devices Companies Case Studies
Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
Figure 12. Clinical Trial Equipment & Ancillary Solutions Report Years Considered
Figure 13. Global Clinical Trial Equipment & Ancillary Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Clinical Trial Equipment & Ancillary Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Region: 2024 VS 2031
Figure 16. Global Clinical Trial Equipment & Ancillary Solutions Market Share by Players in 2024
Figure 17. Global Top Clinical Trial Equipment & Ancillary Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Equipment & Ancillary Solutions as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Clinical Trial Equipment & Ancillary Solutions Revenue in 2024
Figure 19. North America Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Clinical Trial Equipment & Ancillary Solutions Market Share by Country (2020-2031)
Figure 21. United States Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Clinical Trial Equipment & Ancillary Solutions Market Share by Country (2020-2031)
Figure 25. Germany Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market Share by Region (2020-2031)
Figure 33. China Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Clinical Trial Equipment & Ancillary Solutions Market Share by Country (2020-2031)
Figure 41. Mexico Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Share by Country (2020-2031)
Figure 45. Turkey Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Clinical Trial Equipment & Ancillary Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Almac Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 49. Ancillare Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 50. Avantor Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 51. Emsere Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 52. Eurofins Scientific Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 53. Imperial Clinical Research Services Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 54. IRM Europe Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 55. Marken Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 56. Myonex Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 57. Parexel International Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 58. Piramal Pharma Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 59. Recipharm Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 61. Woodley Equipment Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 62. Quipment SAS Revenue Growth Rate in Clinical Trial Equipment & Ancillary Solutions Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232